Stockreport

1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right. [Yahoo! Finance]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF to reach $16 -- an increase of 45% over her prior estimate -- there's a clear consensus about the stock forming on Wall Street. Based on Semenkow's price target, which i [Read more]